<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37511050</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>14</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>10</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Association of <i>IL10RA</i>, <i>IL10RB</i>, and <i>IL22RA</i> Polymorphisms/Haplotypes with Susceptibility to and Clinical Manifestations of SLE.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">11292</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms241411292</ELocationID><Abstract><AbstractText>Systemic lupus erythematosus (SLE) is characterized by an imbalance between proinflammatory and anti-inflammatory mediators. Single-nucleotide polymorphisms (SNPs) in genes coding <i>IL10RA</i>, <i>IL10RB</i>, and <i>IL22RA</i> could affect their expression or function and disrupt immune homeostasis. We aimed to analyze the associations of <i>IL10RA</i>, <i>IL10RB</i>, and <i>IL22RA</i> polymorphisms/haplotypes with patients' susceptibility to and clinical manifestations of SLE. Our study included 103 SLE patients and 99 healthy controls. The genotypes of the selected polymorphisms within <i>IL10RA</i> (rs10892202, rs4252270, rs3135932, rs2228055, rs2229113, and rs9610), <i>IL10RB</i> (rs999788, rs2834167, and rs1058867), and <i>IL22RA</i> (rs3795299 and rs16829204) genes were determined by TaqMan<sup>&#xae;</sup> Assays. <i>IL10RB</i> rs1058867 G allele carriers were significantly more frequent among the controls than among the SLE patients (76.8% vs. 61.2%; <i>p</i> = 0.017, OR = 0.477, 95% CI: 0.258-0.879). The <i>IL10RB</i> CAA haplotype was more frequent among the SLE patients than in the control group (42.7% vs. 30.7%; <i>p</i> = 0.027). The <i>IL22RA</i> rs3795299 C allele and rs16829204 CC genotype were associated with Hashimoto thyroiditis in the SLE patients (n = 103; <i>p</i> = 0.002 and <i>p</i> = 0.026, respectively), and in all the included participants (n = 202, <i>p</i> &lt; 0.000 and <i>p</i> = 0.007, respectively), and the <i>IL22RA</i> CC haplotype was more frequent in the SLE patients with Hashimoto thyroiditis (<i>p</i> = 0.047) and in the overall participants with Hashimoto thyroiditis (n = 32, <i>p</i> = 0.004). The <i>IL10RA</i>, <i>IL10RB</i>, and <i>IL22RA</i> polymorphisms/haplotypes could be associated with SLE susceptibility and various clinical manifestations, and the <i>IL22RA</i> CC haplotype could be associated with Hashimoto thyroiditis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Grk</LastName><ForeName>Milka</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7534-9608</Identifier><AffiliationInfo><Affiliation>Institute of Human Genetics, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miskovic</LastName><ForeName>Rada</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-0982-2572</Identifier><AffiliationInfo><Affiliation>Clinic of Allergy and Immunology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Internal Medicine Department, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeremic</LastName><ForeName>Ivica</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Internal Medicine Department, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Rheumatology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Basaric</LastName><ForeName>Milica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Rheumatology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dusanovic Pjevic</LastName><ForeName>Marija</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3564-2623</Identifier><AffiliationInfo><Affiliation>Institute of Human Genetics, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jekic</LastName><ForeName>Biljana</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute of Human Genetics, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miljanovic</LastName><ForeName>Danijela</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-9446-8701</Identifier><AffiliationInfo><Affiliation>Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lazarevic</LastName><ForeName>Ivana</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-6795-1378</Identifier><AffiliationInfo><Affiliation>Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Despotovic</LastName><ForeName>Aleksa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Medical Statistics and Informatics, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cirkovic</LastName><ForeName>Andja</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Medical Statistics and Informatics, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banko</LastName><ForeName>Ana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6829-096X</Identifier><AffiliationInfo><Affiliation>Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>6060866</GrantID><Agency>Science Fund of the Republic of Serbia</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C081846">IL10RB protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053709">Interleukin-10 Receptor alpha Subunit</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053710">Interleukin-10 Receptor beta Subunit</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C415369">interleukin-22 receptor</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006239" MajorTopicYN="N">Haplotypes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050031" MajorTopicYN="N">Hashimoto Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053709" MajorTopicYN="Y">Interleukin-10 Receptor alpha Subunit</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053710" MajorTopicYN="Y">Interleukin-10 Receptor beta Subunit</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hashimoto thyroiditis</Keyword><Keyword MajorTopicYN="N">IL10RA</Keyword><Keyword MajorTopicYN="N">IL10RB</Keyword><Keyword MajorTopicYN="N">IL22RA</Keyword><Keyword MajorTopicYN="N">polymorphism</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>1</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37511050</ArticleId><ArticleId IdType="pmc">PMC10379357</ArticleId><ArticleId IdType="doi">10.3390/ijms241411292</ArticleId><ArticleId IdType="pii">ijms241411292</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aringer M., Costenbader K., Daikh D., Brinks R., Mosca M., Ramsey-Goldman R., Smolen J.S., Wofsy D., Boumpas D.T., Kamen D.L., et al. 2019 European League against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71:1400&#x2013;1412. doi: 10.1002/art.40930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40930</ArticleId><ArticleId IdType="pmc">PMC6827566</ArticleId><ArticleId IdType="pubmed">31385462</ArticleId></ArticleIdList></Reference><Reference><Citation>Benseler S.M., Silverman E.D. Systemic Lupus Erythematosus. Pediatr. Clin. N. Am. 2005;52:443&#x2013;467. doi: 10.1016/j.pcl.2005.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcl.2005.01.010</ArticleId><ArticleId IdType="pubmed">15820375</ArticleId></ArticleIdList></Reference><Reference><Citation>Almaani S., Meara A., Rovin B.H. Update on lupus nephritis. Clin. J. Am. Soc. Nephrol. 2017;12:825&#x2013;835. doi: 10.2215/CJN.05780616.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.05780616</ArticleId><ArticleId IdType="pmc">PMC5477208</ArticleId><ArticleId IdType="pubmed">27821390</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y.R., Hsing C.H., Chiu C.J., Huang H.Y., Hsu Y.H. Roles of IL-1 and IL-10 family cytokines in the progression of systemic lupus erythematosus: Friends or foes? IUBMB Life. 2022;74:143&#x2013;156. doi: 10.1002/iub.2568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.2568</ArticleId><ArticleId IdType="pubmed">34668305</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswas S., Bieber K., Manz R.A. IL-10 revisited in systemic lupus erythematosus. Front. Immunol. 2022;13:4229. doi: 10.3389/fimmu.2022.970906.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.970906</ArticleId><ArticleId IdType="pmc">PMC9376366</ArticleId><ArticleId IdType="pubmed">35979356</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng H., Wang W., Zhou M., Li R., Pan H.F., Ye D.Q. Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus. Clin. Rheumatol. 2013;32:1255&#x2013;1266. doi: 10.1007/s10067-013-2294-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-013-2294-3</ArticleId><ArticleId IdType="pubmed">23708831</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabat R., Gr&#xfc;tz G., Warszawska K., Kirsch S., Witte E., Wolk K., Geginat J. Biology of interleukin-10. Cytokine Growth Factor Rev. 2010;21:331&#x2013;344. doi: 10.1016/j.cytogfr.2010.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2010.09.002</ArticleId><ArticleId IdType="pubmed">21115385</ArticleId></ArticleIdList></Reference><Reference><Citation>Saraiva M., Vieira P., O&#x2019;garra A. Biology and therapeutic potential of interleukin-10. J. Exp. Med. 2019;217:e20190418. doi: 10.1084/jem.20190418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20190418</ArticleId><ArticleId IdType="pmc">PMC7037253</ArticleId><ArticleId IdType="pubmed">31611251</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma R., Balakrishnan L., Sharma K., Khan A.A., Advani J., Gowda H., Tripathy S.P., Suar M., Pandey A., Gandotra S., et al. A network map of Interleukin-10 signaling pathway. J. Cell Commun. Signal. 2016;10:61&#x2013;67. doi: 10.1007/s12079-015-0302-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12079-015-0302-x</ArticleId><ArticleId IdType="pmc">PMC4850137</ArticleId><ArticleId IdType="pubmed">26253919</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouyang W., Rutz S., Crellin N.K., Valdez P.A., Hymowitz S.G. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 2011;29:71&#x2013;109. doi: 10.1146/annurev-immunol-031210-101312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-031210-101312</ArticleId><ArticleId IdType="pubmed">21166540</ArticleId></ArticleIdList></Reference><Reference><Citation>Rom&#xe1;n-Fern&#xe1;ndez I.V., Machado-Contreras J.R., Mu&#xf1;oz-Valle J.F., Cruz A., Salazar-Camarena D.C., Palafox-S&#xe1;nchez C.A. Altered PTPN22 and IL10 mRNA Expression Is Associated with Disease Activity and Renal Involvement in Systemic Lupus Erythematosus. Diagnostics. 2022;12:2859. doi: 10.3390/diagnostics12112859.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12112859</ArticleId><ArticleId IdType="pmc">PMC9689646</ArticleId><ArticleId IdType="pubmed">36428917</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;hl H. Pro-inflammatory signaling by IL-10 and IL-22: Bad habit stirred up by interferons? Front. Immunol. 2013;4:18. doi: 10.3389/fimmu.2013.00018.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2013.00018</ArticleId><ArticleId IdType="pmc">PMC3562761</ArticleId><ArticleId IdType="pubmed">23382730</ArticleId></ArticleIdList></Reference><Reference><Citation>Kehrl J.H., Muraguchi A., Butler J.L., Falkoff R.J., Fauci A.S. Human B cell activation; proliferation and differentiation. Immunol. Rev. 1984;78:75&#x2013;96. doi: 10.1111/j.1600-065X.1984.tb00477.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.1984.tb00477.x</ArticleId><ArticleId IdType="pubmed">6203826</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng H., Liu C.Y., Zhou M., Wen P.F., Zhang M., Qiu L.J., Ni J., Liang Y., Pan H.-F., Ye D.-Q. IL-10RB rs2834167 (A/G) polymorphism is associated with the susceptibility to systemic lupus erythematosus: Evidence from a study in Chinese Han population. Inflammation. 2013;36:1218&#x2013;1224. doi: 10.1007/s10753-013-9658-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-013-9658-3</ArticleId><ArticleId IdType="pubmed">23749100</ArticleId></ArticleIdList></Reference><Reference><Citation>Goulielmos G.N., Zervou M.I., Vazgiourakis V.M., Ghodke-Puranik Y., Garyfallos A., Niewold T.B. The genetics and molecular pathogenesis of systemic lupus erythematosus (SLE) in populations of different ancestry. Gene. 2018;668:59&#x2013;72. doi: 10.1016/j.gene.2018.05.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2018.05.041</ArticleId><ArticleId IdType="pubmed">29775752</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer S.S., Cheng G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit. Rev. Immunol. 2012;32:23&#x2013;63. doi: 10.1615/CritRevImmunol.v32.i1.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1615/CritRevImmunol.v32.i1.30</ArticleId><ArticleId IdType="pmc">PMC3410706</ArticleId><ArticleId IdType="pubmed">22428854</ArticleId></ArticleIdList></Reference><Reference><Citation>Csiszar A., Nagy G.Y., Gergely P., Pozsonyi T., Pocsik E. Increased interferon-gamma (IFN-&#x3b3;); IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 2000;122:464&#x2013;470. doi: 10.1046/j.1365-2249.2000.01369.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2249.2000.01369.x</ArticleId><ArticleId IdType="pmc">PMC1905797</ArticleId><ArticleId IdType="pubmed">11122256</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu P., Song J., Su H., Li L., Lu N., Yang R., Peng Z. IL-10 gene polymorphisms and susceptibility to systemic lupus erythematosus: A meta-analysis. PLoS ONE. 2013;8:e69547. doi: 10.1371/journal.pone.0069547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0069547</ArticleId><ArticleId IdType="pmc">PMC3720721</ArticleId><ArticleId IdType="pubmed">23936042</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadi S., Saghaeian Jazi M., Zare Ebrahimabad M., Eghbalpour F., Abdolahi N., Tabarraei A., Yazdani Y. Interleukin 10 gene promoter polymorphisms (rs1800896, rs1800871 and rs1800872) and haplotypes are associated with the activity of systemic lupus erythematosus and IL10 levels in an Iranian population. Int. J. Immunogenet. 2019;46:20&#x2013;30. doi: 10.1111/iji.12407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/iji.12407</ArticleId><ArticleId IdType="pubmed">30430731</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Zhu T., Cai G., Qin Y., Wang W., Tang G., Zhao D., Shen Q. Elevated circulating CD4+ ICOS+ Foxp3+ T cells contribute to overproduction of IL-10 and are correlated with disease severity in patients with systemic lupus erythematosus. Lupus. 2011;20:620&#x2013;627. doi: 10.1177/0961203310392431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203310392431</ArticleId><ArticleId IdType="pubmed">21558138</ArticleId></ArticleIdList></Reference><Reference><Citation>Mellor-Pita S., Citores M.J., Castejon R., Yebra-Bango M., Tutor-Ureta P., Rosado S., Andreu J.L., Vargas J.A. Monocytes and T lymphocytes contribute to a predominance of interleukin 6 and interleukin 10 in systemic lupus erythematosus. Cytom. Part B Clin. Cytom. J. Int. Soc. Anal. Cytol. 2009;76:261&#x2013;270. doi: 10.1002/cyto.b.20468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cyto.b.20468</ArticleId><ArticleId IdType="pubmed">19199277</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermann J., Gruber S., Neufeld J.B., Grundtner P., Graninger M., Graninger W.B., Berghold A., Gasche C. IL10R1 loss-of-function alleles in rheumatoid arthritis and systemic lupus erythematosus. Clin. Exp. Rheumatol. 2009;27:603&#x2013;608.</Citation><ArticleIdList><ArticleId IdType="pubmed">19772791</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X.K., Li P., Li S., Zhang C., Li B.Z., Leng R.X., Pan H.-F., Ye D.-Q. Genetic variant of IL-10RA and susceptibility to rheumatoid arthritis in a Chinese population. Clin. Rheumatol. 2017;36:825&#x2013;830. doi: 10.1007/s10067-016-3449-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-016-3449-9</ArticleId><ArticleId IdType="pubmed">27796662</ArticleId></ArticleIdList></Reference><Reference><Citation>1000 Genomes Project Consortium. Auton A., Brooks L., Durbin R., Garrison E., Kang H.M., Korbel J., Marchini J., McCarthy S., McVean G. A global reference for human genetic variation. Nature. 2015;526:68. doi: 10.1038/nature15393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature15393</ArticleId><ArticleId IdType="pmc">PMC4750478</ArticleId><ArticleId IdType="pubmed">26432245</ArticleId></ArticleIdList></Reference><Reference><Citation>Moran C.J., Walters T.D., Guo C.H., Kugathasan S., Klein C., Turner D., Wolters V.M., Bandsma R.H., Mouzaki M., Zachos M., et al. IL-10R polymorphisms are associated with very-early-onset ulcerative colitis. Inflamm. Bowel Dis. 2013;19:115&#x2013;123. doi: 10.1002/ibd.22974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ibd.22974</ArticleId><ArticleId IdType="pmc">PMC3744177</ArticleId><ArticleId IdType="pubmed">22550014</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherry S.T., Ward M.H., Kholodov M., Baker J., Phan L., Smigielski E.M., Sirotkin K. dbSNP: The NCBI database of genetic variation. Nucleic Acids Res. 2001;29:308&#x2013;311. doi: 10.1093/nar/29.1.308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/29.1.308</ArticleId><ArticleId IdType="pmc">PMC29783</ArticleId><ArticleId IdType="pubmed">11125122</ArticleId></ArticleIdList></Reference><Reference><Citation>Hikami K., Ehara Y., Hasegawa M., Fujimoto M., Matsushita M., Oka T., Takehara K., Sato S., Tokunaga K., Tsuchiya N. Association of IL-10 receptor 2 (IL10RB) SNP with systemic sclerosis. Biochem. Biophys. Res. Commun. 2008;373:403&#x2013;407. doi: 10.1016/j.bbrc.2008.06.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2008.06.054</ArticleId><ArticleId IdType="pubmed">18588853</ArticleId></ArticleIdList></Reference><Reference><Citation>Frodsham A.J., Zhang L., Dumpis U., Taib N.A., Best S., Durham A., Hennig B.J.W., Hellier S., Knapp S., Wright M., et al. Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence. Proc. Natl. Acad. Sci. USA. 2006;103:9148&#x2013;9153. doi: 10.1073/pnas.0602800103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0602800103</ArticleId><ArticleId IdType="pmc">PMC1482581</ArticleId><ArticleId IdType="pubmed">16757563</ArticleId></ArticleIdList></Reference><Reference><Citation>Skeeles L.E., Fleming J.L., Mahler K.L., Toland A.E. The impact of 3&#x2032; UTR variants on differential expression of candidate cancer susceptibility genes. PLoS ONE. 2013;8:e58609. doi: 10.1371/journal.pone.0058609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0058609</ArticleId><ArticleId IdType="pmc">PMC3589377</ArticleId><ArticleId IdType="pubmed">23472213</ArticleId></ArticleIdList></Reference><Reference><Citation>Cojocaru M., Cojocaru I.M., Silosi I., Vrabie C.D. Manifestations of systemic lupus erythematosus. Maedica. 2011;6:330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3391953</ArticleId><ArticleId IdType="pubmed">22879850</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinarte V.R., Silva W.A., Jr., Baccarin A.R., Tamashiro E., Valera F.C., Anselmo-Lima W.T. Association of interleukin 22 receptor subunit alpha 1 gene polymorphisms with chronic rhinosinusitis. Braz. J. Otorhinolaryngol. 2021;87:505&#x2013;511. doi: 10.1016/j.bjorl.2019.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjorl.2019.10.006</ArticleId><ArticleId IdType="pmc">PMC9422405</ArticleId><ArticleId IdType="pubmed">31879195</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu Z., Zhao X., Liu H., Quan J., Lin Y., Li J., Wang J., Liu M., Song W., Chen A., et al. Impact of IL-22 and IL-22 receptor alpha 1 polymorphisms on preeclampsia risk in Chinese Han women. J. Cell. Biochem. 2018;119:4656&#x2013;4663. doi: 10.1002/jcb.26640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.26640</ArticleId><ArticleId IdType="pubmed">29274280</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725. doi: 10.1002/art.1780400928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780400928</ArticleId><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladman D.D., Iba&#xf1;ez D., Urowltz M.B. Systemic Lupus Erythematosus Disease Activity Index 2000. J. Rheumatol. 2002;29:288&#x2013;291.</Citation><ArticleIdList><ArticleId IdType="pubmed">11838846</ArticleId></ArticleIdList></Reference><Reference><Citation>Piga M., Chessa E., Morand E.F., Ugarte-Gil M.F., Tektonidou M., van Vollenhoven R., Petri M., Arnaud L., Appenzeller S., Aranow C., et al. Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: The PISCOS Study. Lancet Rheumatol. 2022;4:e441&#x2013;e449. doi: 10.1016/S2665-9913(22)00107-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(22)00107-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller S., Dykes D., Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215. doi: 10.1093/nar/16.3.1215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/16.3.1215</ArticleId><ArticleId IdType="pmc">PMC334765</ArticleId><ArticleId IdType="pubmed">3344216</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett J.C., Fry B., Maller J.D., Daly M.J. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263&#x2013;265. doi: 10.1093/bioinformatics/bth457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bth457</ArticleId><ArticleId IdType="pubmed">15297300</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>